Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An International Multicenter Randomized Controlled Trial to Compare Combined Portal and Hepatic Vein Embolization (PVE/HVE) with PVE Alone in Patients with Colorectal Liver Cancer Metastases (CRLM) and a Small Future Liver Remnant (FLR)

NCT05428735 is registered in ClinicalTrials.gov with Maastricht University as lead sponsor.

NCT NCT05428735
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05428735 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An International Multicenter Randomized Controlled Trial to Compare Combined Portal and Hepatic Vein Embolization (PVE/HVE) with PVE Alone in Patients with Colorectal Liver Cancer Metastases (CRLM) and a Small Future Liver Remnant (FLR)
Lead sponsor
Maastricht University
Phase
Not applicable
Overall status
Recruiting
Start date
April 1, 2022
Completion date
June 30, 2029
Enrollment
348 (estimated)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer liver metastases (crlm), small future liver remnant (flr)